Linvatec Corporation

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$31Mgeneral payments (2019-2025)
$1.3Mresearch payments (2019-2025)
4,296clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1.6M
2020 $1.2M
2021 $1.5M
2022 $14M
2023 $4.2M
2024 $4.6M
2025 $4.2M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Orthopaedic Surgery $12M
Sports Medicine (Orthopaedic Surgery) $7.3M
Foot & Ankle Surgery $4.8M
Podiatrist $3.6M
Foot and Ankle Surgery $1.8M
Hand Surgery $884K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Nirav Amin Placentia, CA Orthopaedic Surgery $3,711,231.29
Jeffrey Abrams Princeton, NJ Orthopaedic Surgery $1,354,705.21
David Welker Miamisburg, OH Orthopaedic Surgery $1,010,149.27
Gary Lepow Houston, TX Podiatrist $917,706.93
Felix Savoie New Orleans, LA Sports Medicine (Orthopaedic Surgery) $874,951.68
Sean Mcmillan Burlington, NJ Sports Medicine (Orthopaedic Surgery) $786,559.67
Travis Hanson Houston, TX Orthopaedic Surgery $710,123.74
Keith Heier Carrollton, TX Orthopaedic Surgery $695,394.88
Kevin Varner Houston, TX Foot and Ankle Surgery $665,433.36
Stephen Snyder Van Nuys, CA Sports Medicine (Orthopaedic Surgery) $661,356.27

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.